(Q47878117)

6 February 2018

title

The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more (English)

1 reference

6 February 2018

1 reference

1 reference

Reese H Clark

1

1 reference

6 February 2018

publication date

1 April 2005

1 reference

6 February 2018

published in

Journal of Perinatology

1 reference

6 February 2018

volume

25

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

251-257

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.jp.7211242

exact match

0 references

cites work

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Variations in practice and outcomes in the Canadian NICU network: 1996-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

A comparison of clinical variables that predict adverse outcome in term infants with severe respiratory failure randomised to a policy of extracorporeal membrane oxygenation or to conventional neonatal intensive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Epidemiology of neonatal respiratory failure in the United States: projections from California and New York

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Hidden mortality rate associated with extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

The Changing Demographics of Neonatal Extracorporeal Membrane Oxygenation Patients Reported to the Extracorporeal Life Support Organization (ELSO) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

Nitric oxide for respiratory failure in infants born at or near term

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211242

7 January 2021

Identifiers

DOI

10.1038/SJ.JP.7211242

1 reference

6 February 2018

Dimensions Publication ID

1036803217

0 references

1 reference

6 February 2018